Vector BioMed COO Mike Kadan on Reinventing Viral Vector Manufacturing for a Decentralized Gene Therapy Future

In this exclusive interview with BioPharma BoardRoom, Mike Kadan, Chief Operating Officer of Vector BioMed, shares how the company is reimagining viral vec...

April 25, 2025 | Friday | Interview
Sanofi CEO Paul Hudson Confident in 2025 Growth Trajectory as Q1 Sales Climb 9.7% and Pipeline Delivers Six Approvals

CEO Paul Hudson: Confidence in Full-Year Outlook Paul Hudson, Chief Executive Officer: “We had a strong start in 2025 with sales growth of 9.7%, b...

April 24, 2025 | Thursday | Company results
Adcentrx Therapeutics to Present First Clinical Data for ADC Candidate ADRX-0706 at 2025 ASCO Annual Meeting

Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and...

April 24, 2025 | Thursday | News
Antengene to Present Promising Clinical Data on ATG-037 and ATG-008 at 2025 ASCO Annual Meeting

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commer...

April 24, 2025 | Thursday | News
Manufacture in America, Win in America: Why Big Pharma Is Betting $160 Billion on U.S. Soil

      Global pharmaceutical giants have unveiled over $160 billion in fresh U.S. investments within just the past few...

April 24, 2025 | Thursday | Analysis
Dupixent Secures FDA Nod for Chronic Spontaneous Urticaria in Patients Unresponsive to Antihistamines

Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and hives compared to placebo In the US, there are more than 300,0...

April 21, 2025 | Monday | News
Daiichi Sankyo and AstraZeneca’s ENHERTU Combo Outperforms Standard of Care in First-Line HER2+ Metastatic Breast Cancer

DESTINY-Breast09 phase 3 trial of Daiichi Sankyo and AstraZeneca’s ENHERTU is the first trial in more than a decade to demonstrate superior eff...

April 21, 2025 | Monday | News
Intuitive Research Confirms Robotic-Assisted Surgery Expands Access to High-Quality Care in Medically Remote Regions

  Intuitive , a global leader in minimally invasive care and the pioneer of robotic-assisted surgery (RAS),  announced the publication of two st...

April 18, 2025 | Friday | Reports
Actum Launches New Life Sciences Platform, Taps Top Industry Leaders to Tackle Biopharma’s Critical Challenges

Actum Pharma (Actum), a strategy and operating business partner to global biopharma manufacturers, today announces two executive appointments to launch a...

April 18, 2025 | Friday | News
Thermo Fisher Opens Doors to the Future of Cell Therapy Manufacturing in Carlsbad

Innovative 6,000-square-foot facility enables clinical and commercial process development support to help cell therapy developers transition from researc...

April 18, 2025 | Friday | News
White House Fires First Shot in Global Pharma Trade War: National Security Probe Targets Imported Drugs

    The Trump administration has launched a bold and controversial national security investigation into America’s heavy reliance on impor...

April 17, 2025 | Thursday | Reports
Hyperfine Enrolls First Patients in Landmark Study Comparing Portable and High-Field MRI in Neurology

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered porta...

April 16, 2025 | Wednesday | News
Radiance Biopharma Doses First Patient in China in Phase 1 Trial of ROR-1 Targeting ADC RB-164™

Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjug...

April 16, 2025 | Wednesday | News
Boehringer Ingelheim and Cue Biopharma Partner to Advance First-in-Class B Cell Depletion Therapy for Autoimmune Diseases

Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The ...

April 15, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close